Aromatic amino acids are protein building blocks and precursors to a number of plant natural products, such as the structural polymer lignin and a variety of medicinally relevant compounds. Plants make tyrosine and phenylalanine by a different pathway from many microbes; this pathway requires prephenate aminotransferase (PAT) as the key enzyme. Prephenate aminotransferase produces arogenate, the unique and immediate precursor for both tyrosine and phenylalanine in plants, and also has aspartate aminotransferase (AAT) activity. The molecular mechanisms governing the substrate specificity and activation or inhibition of PAT are currently unknown. Here we present the X-ray crystal structures of the wild-type and various mutants of PAT from Arabidopsis thaliana (AtPAT). Steady-state kinetic and ligand-binding analyses identified key residues, such as Glu108, that are involved in both keto acid and amino acid substrate specificities and probably contributed to the evolution of PAT activity among class Ib AAT enzymes. Structures of AtPAT mutants co-crystallized with either a-ketoglutarate or pyridoxamine 5 0 -phosphate and glutamate further define the molecular mechanisms underlying recognition of keto acid and amino acid substrates. Furthermore, cysteine was identified as an inhibitor of PAT from A. thaliana and Antirrhinum majus plants as well as the bacterium Chlorobium tepidum, uncovering a potential new effector of PAT.
INTRODUCTION
Throughout evolution, fungi, bacteria and plants maintained the machinery necessary to synthesize aromatic amino acids de novo (Tzin and Galili, 2010; Maeda and Dudareva, 2012; Tohge et al., 2013) . Aromatic amino acids are precursors of multiple physiologically important metabolites, including phytohormones such as auxins and salicylic acid, the structural polymer lignin, flavonoids, vitamin E and alkaloids (Boerjan et al., 2003; Hunter and Cahoon, 2007; Yu and Jez, 2008; Zhao, 2012; Hagel and Facchini, 2013; Gleadow and Møller, 2014; Cook et al., 2016) . Additionally, aromatic amino acid biosynthetic pathways are potential targets of antimicrobials and plant herbicides (Sch€ onbrunn et al., 2001; Reichau et al., 2011) . In plants and microbes, phenylalanine and tyrosine biosynthesis both stem from the precursor prephenate, which is formed from chorismate (Romero et al., 1995; Westfall et al., 2014) . In this pathway, prephenate dehydrogenase or prephenate dehydratase decarboxylate prephenate into either 4-hydroxyphenylpyruvate (4-HPP) or phenylpyruvate, respectively (Bentley, 1990 ). An aminotransferase next converts the resulting a-keto acid (i.e. 4-HPP or phenylpyruvate) to an amino acid (i.e. tyrosine or phenylalanine). Plants, and some microbes, use an alternative pathway to synthesize these amino acids via arogenate (Eberhard et al., 1996; Mobley et al., 1999; Colquhoun et al., 2010; Maeda et al., 2010) . In this pathway, prephenate aminotransferase (PAT) catalyzes the first step by aminating prephenate into arogenate (Bonner and Jensen, 1985; Graindorge et al., 2010; Maeda et al., 2011) (Figure 1) . Decarboxylation of arogenate by either arogenate dehydrogenase or arogenate dehydratase yields either tyrosine or phenylalanine, respectively (Jung et al., 1986; Cho et al., 2007; Rippert et al., 2009; Maeda et al., 2010; ) .
Much of what is known about aromatic amino acid biosynthesis in plants is inferred from microbial investigations (Maeda and Dudareva, 2012) , but the modulation of aromatic amino acid metabolism in plants is not well understood. Although PAT activity has been detected in various plants (Rubin and Jensen, 1979; Bonner and Jensen, 1985; Siehl et al., 1986; de la Torre et al., 2014; Kilpatrick et al., 2016) , the gene encoding a plant PAT was only recently identified in Arabidopsis (i.e. AtPAT) (Graindorge et al., 2010; Maeda et al., 2011) . Prephenate aminotransferase has a dual role in metabolism and can also function as an aspartate aminotransferase (AAT). The reaction catalyzed by PAT involves the reversible transfer of the a-amino group of aspartate to a keto acid substrate, either a-ketoglutarate or prephenate, generating oxaloacetate and either glutamate or arogenate, respectively. Pyridoxal 5 0 -phosphate (PLP) serves as a cofactor to accept the amino group for transfer to a keto acid. In Arabidopsis, an embryo-lethal mutant identified in a screen was mapped to PAT (Pagnussat et al., 2005) . RNA interference (RNAi) suppression of PAT in petunia did not affect AAT activity, suggesting that PAT does not significantly contribute to the overall AAT activity in plants but is contributing to aromatic amino acids (Maeda et al., 2011) . Similarly, virus-induced gene silencing of PAT in tobacco led to plants that were significantly reduced in stature and had a decreased lignin content, reduced chlorophyll content and lower levels of free asparagine, while aspartate and glutamate levels remained unchanged compared with the wild-type (de la Torre et al., 2014) .
Previous biochemical studies of plant PATs revealed a higher specific activity with prephenate than with arogenate (Maeda et al., 2011) ; however, detailed kinetic and ligand-binding analyses of a plant PAT remain to be performed. A phylobiochemical investigation identified two residues (Thr84 and Lys169 in AtPAT) that were conserved among PATs but were absent in AATs (Dornfeld et al., 2014) . Corresponding residues are also critical for binding of dicarboxylates in the orthologous enzyme from Thermus thermophilus, which belongs to the class Ib AAT family (Nobe et al., 1998; Nakai et al., 1999; Ura et al., 2001; Wang and Maeda, 2017) . The T84V and K169V mutants of AtPAT significantly reduce PAT activity (Dornfeld et al., 2014) . Interestingly, the T84V/K169V mutant lost function with prephenate but gained activity with alanine and tryptophan as amino donors and with 4-HPP as the keto acid. Without three-dimensional structural data, the positioning of these residues in the context of the active site remains unclear. Considering how critical PAT is for proper growth and development in plants, surprisingly little is known about the mechanisms governing its reaction chemistry. Here we present a structure/function analysis of AtPAT that yields new insight into keto and amino acid recognition and identifies cysteine as an inhibitor of AtPAT, as well as other plant and microbial homologs.
RESULTS
Crystal structures of wild-type and K306A mutant AtPAT
To understand the molecular determinants of substrate binding, the three-dimensional structure of AtPAT co-complexed with PLP was solved by molecular replacement and refined to 3.0-A resolution (Table S1 , Supporting Information, Figure 2a) . AtPAT crystallized as a homodimer. Each monomer of AtPAT consists of 15 a-helices and 9 b-strands divided between two structural domains. The N-terminal domain (Lys115-Leu353) contains two sets of three a-helices surrounding six parallel and one anti-parallel b-strand. Two additional a-helices in the PLP-binding pocket, as well as the a-helix connecting the N-and C-terminal domains, complete the N-terminal domain. The smaller C-terminal domain contains part of the N-terminal region (Ser71-Pro114) and residues Gly354 through Leu469, totaling five a-helices and two b-strands. The N-terminal flexible loop (Ser71-Ser82) and features of the N-terminal domain form the dimer interface.
Pyridoxal 5 0 -phosphate is bound in the active site of each chain in the wild-type structure with clear electron density ( Figure S1a ) and defines key residues in the active site (Figure 2b) . A catalytic lysine forms a Schiff base with the PLP through its e-nitrogen, accounting for the active form of the resting enzyme (Malashkevich et al., 1993) . In the AtPAT crystal structure, PLP is covalently linked to the e-nitrogen of Lys306 to form the internal aldimine (i.e. Schiff base). Trp193 and Ile274 position the ring of PLP through p-p stacking and van der Waals interactions, respectively. The pyridine ring nitrogen of PLP forms a charge-charge interaction with the side chain of Asp272, an interaction that is characteristic of aminotransferases such as PAT and AAT (Toney, 2014) . The hydroxyl of Tyr275 and the side-chain amide nitrogen of Asn243 orient the PLP ring hydroxyl group to direct the reactive aldehyde toward the catalytic Lys. The phosphate-binding pocket is formed by polar contacts to Ser305 and the side-chain hydroxyl of Tyr132 from the other monomer. Chargecharge interactions between the PLP phosphate and the side chain of Arg314 and the backbone amines of Ala168 and Lys169 complete the PLP-binding pocket. Based on the wild-type structure, Lys306 was postulated to be the catalytic Lys in AtPAT. To capture ligands in the AtPAT active site, Lys306 was mutated to an alanine and the K306A mutant was crystallized and solved by molecular replacement at 2.1-A resolution (Table S1 ). The overall structure is similar to that of the wild-type AtPAT structure [root mean square deviation (rmsd) of 1.35 A 2 for 368 C a atoms] (Figure 2c ). In the AtPAT K306A crystal structure, the alanine substitution of Lys306 prevents Schiff base formation with the cofactor. Instead, both PMP and a ligand, which was modeled as a Glu in the electron density (Figure S1b) , were observed in the active site. In the active site of AtPAT K306A the interaction network with PMP is similar to that of the wild-type. There is a 5-A shift in the position of a1 into the active site in the mutant structure compared with the wild-type (Figure 2d ). Movement of a1 toward the bound ligand potentially allows the hydroxyl of Thr84 to interact with either the keto or amino acid ligands. In the closed state, the side-chain hydroxyl of Thr84 is 3.8 A away from the backbone amine of the glutamate ligand.
The carboxylate side chain of the glutamate forms chargecharge interactions with the side-chain nitrogen of Lys169 and hydrogen bonds to a water molecule. The backbone oxygen of the amino acid is stabilized by interactions with the side-chain nitrogen of Arg445 and the backbone nitrogen of Gly107. A polar contact between the backbone carboxylate and the side-chain hydroxyl of Tyr275 completes the ligand-protein interactions. Thus, the structure of the K306A mutant identified the residues critical for ligand binding in the presence of the cofactor.
Biochemical analysis of active site mutants
To identify residues important for prephenate specificity, active site residues of AtPAT ( Figure 2 ) were compared with closely related class Ib AAT and more distantly related class Ia AAT ( Figure S2 ). As expected, the residue corresponding to the catalytic Lys306 is conserved in all of the sequences. Similarly, PLP-binding residues, such as Gly107, Tyr132 and Arg314, are conserved in each protein.
In the putative substrate-binding pocket, residues corresponding to Asn243 and Tyr275 of AtPAT are conserved in all AATs. The Ile274 of AtPAT is an Ala in class Ia AATs but is conserved in class Ib AATs. Previously identified active site residues Thr84 and Lys169 are only conserved among PATs, and the region containing Thr84 at the start of a1 is absent in the class Ia AATs. Other residues in the PLP-(i.e. Ala168) and substrate-binding sites (i.e. Glu108 and Arg445) vary in the AATs ( Figure S2 ).
To test the function of these active site residues experimentally, the AtPAT E108K, A168G, K169S and R445G mutants were generated for functional analysis. The mutants together with previously generated AtPAT T84V, K169V and T84V/K169V mutants were expressed and purified as described for the wild-type enzyme. Using a coupled assay system, the steady-state kinetic properties of wild-type and mutant AtPAT were determined (Table 1) . With varied aspartate concentrations and a fixed concentration of a-ketoglutarate, K m Asp is 1.9 mM with a turnover rate (k cat ) of 560 min À1 . For the keto acid substrates, assayed at a fixed aspartate concentration, the catalytic efficiency (k cat /K m ) for prephenate is three-fold higher than that of a-ketoglutarate.
Of the eight AtPAT mutants analyzed, only the T84V, E108K and A168G proteins were active with Asp as an amino donor (Table 1 ). The T84V mutant had a K m Asp comparable to the wild-type enzyme, but the E108K and A168G mutations modestly increased the K m for this substrate and reduced k cat /K m compared with the wild-type. The AtPAT T84V and A168G mutants displayed two-fold higher catalytic efficiency with a-ketoglutarate than with prephenate. In assays where prephenate was varied for the AtPAT E108K mutant, the velocity versus substrate concentration plots were linear to a concentration of 2 mM, indicating that the E108K substitution greatly reduced affinity for prephenate; however, the enzyme was still active with a-ketoglutarate and displayed a catalytic efficiency similar to the wild-type. This result indicates that the E108K mutation is functional as an AAT but has substantially reduced activity with prephenate. Thus, Glu108 plays a critical role in the prephenate substrate specificity of PAT.
AtPAT amino donor-binding analysis
Given that five of the eight mutants analyzed lacked full aminotransferase activity, we evaluated binding of amino acids to AtPAT and the site-directed mutants using UV/Vis spectroscopy. Titration of PLP-dependent AATs with amino acids allows for conversion of the pyridoxal (i.e. PLP) form (k max = 390 nm) to the pyridoxamine (i.e. PMP) form (k max = 330 nm), which can be monitored to determine apparent K d values for the added ligand (Kirsch et al., 1984; Ziak et al., 1990; Karsten and Cook, 2009 ). For example, AtPAT displays a mixture of E-PLP (A 330 nm peak) and E-PMP (A 330 nm ) forms ( Figure S3 , red line), but with aspartate titration a decrease in the PLP signal and an increase in the PMP signal was observed ( Figure S3 , purple line). For comparison of wild-type and mutant AtPAT, titrations of each protein using aspartate, glutamate, alanine, tryptophan and tyrosine were performed. Wild-type AtPAT and all the mutants except for K169S and K306A bound Asp ( Table 2 ). The T84V and K169V mutants had K d values similar to the wild-type, but the E108K and A168G mutants bound aspartate with three-to six-fold tighter affinity. In contrast, the R445G and T84V/K169V mutants decreased affinity up to three-fold. With titrations using glutamate, only the wild-type, E108K and A168G AtPAT showed changes in the spectra, with the E108K substitution leading to a 22-fold decrease in binding affinity compared with AtPAT. The T84V, A168G, K169V, K169S, R445G and T84V/ K169V PAT mutants bound alanine to varying degrees, whereas wild-type AtPAT did not bind alanine. In earlier work (Dornfeld et al., 2014) , the amino donor for AtPAT was changed from aspartate to tryptophan in the T84V/ K169V double mutant. To analyze this specificity change further, the binding of tryptophan and tyrosine was assessed (Table 2) . Surprisingly, the wild-type enzyme had the highest binding affinity (3.6 mM) for tryptophan, although the K d was still higher than that of either aspartate or glutamate. Except for the A168G, K306A and R445G mutants, all of the AtPAT variants also retained tryptophan binding, but with decreased affinities. Using tyrosine, only the E108K and K169V mutants exhibited binding. Overall, 
Cysteine inhibits plant and microbial PATs
Because of the relaxed specificity in amino acid binding with AtPAT, the effect of all 20 proteogenic amino acids was analyzed to determine if any act as either positive or negative effectors of PAT activity ( Figure S4) . Surprisingly, cysteine reduced AtPAT activity with a-ketoglutarate (IC 50 = 0.56 mM) and with prephenate (IC 50 = 0.75 mM) (Figure 3a) . To our knowledge, metabolite effectors of a PAT have not been previously reported from either a microbial or plant source. Earlier work suggests that the evolutionary basis for PAT acquisition in plants was lateral gene transfer from Chlorobi/Bacteroidetes (Dornfeld et al., 2014) . To test if cysteine also inhibited PAT homologs in other plants and in microbes, two previously characterized PATs from Antirrhinum majus (snapdragon) and Chlorobium tepidum (a Gram-negative, thermophilic green sulfur bacterium) were assayed for potential inhibition (Figure 3a) . Cysteine inhibited both AmPAT and CtPAT with similar IC 50 values (1.3 mM). All the active site residues of AtPAT are highly conserved in the A. majus and C. tepidum enzymes except for Ala168 and Ile274, which are Gly106 in CtPAT and Met211 in AmPAT, respectively.
To determine if cysteine reacted with PLP, wild-type and mutant AtPAT were titrated with cysteine and the shift in spectra from PLP to PMP forms measured. With wild-type AtPAT, changes in the spectra between forms were observed and yielded a K d of 0.61 mM (Table S2) (Table S2) were also comparable to the IC 50 values determined from enzymatic assays (Figure 3a ).
Crystal structures of AtPAT T84V and T84V/K169V mutants
Sequence comparisons of known functional PATs and biochemical analysis identified Thr84 and Lys169 of AtPAT as determinants of PAT versus AAT activity (Dornfeld et al., 2014) . To rationalize the biochemical data presented here and in the earlier study, the X-ray crystal structures of AtPAT T84V in complex with a-ketoglutarate and AtPAT T84V/K169V with bound malate and borate (both from the crystallization buffer) were refined to 2.0-A and 1.4-A resolution, respectively (Table S1 ).
The T84V mutant is structurally similar to the wild-type enzyme (rmsd = 0.66 A 2 for 350 C a atoms) (Figure 4a ).
Clear electron density for a-ketoglutarate ( Figure S1c ) was observed, with the ligand making similar contacts as described for glutamate in the AtPAT K306A structure (Figure 4b ). In the absence of cofactor, the phosphate-binding residue Arg314 shifts to partially fill the site where PLP would bind. The hydroxyl on the b-carbon of the ligand interacts with the ring nitrogen of Trp193. The a-carbon of a-ketoglutarate forms ionic interactions with the side-chain nitrogens of Arg445 and Asn243, along with the mainchain amide of Gly107. The a1 helix, where residue 84 is found, moves 5 A toward the catalytic lysine; however, this could be an artifact of the absence of the cofactor and the presence of a small ligand. The AtPAT T84V/K169V structure is more similar to the AtPAT T84V structure (rmsd = 0.358 A 2 for 384 C a atoms)
than to the wild-type (rmsd = 0.753 A 2 for 346 C a atoms).
Like the AtPAT T84V structure, a1 shifts into the active site (Figure 4c ). The positioning of the a4 helix that contains the K169V mutation remains unchanged. Malate and borate were bound in the AtPAT double mutant active site (Figure 4d ). The carboxylates of malate form hydrogenbond interactions with Tyr275 and charge-charge 
interactions with Gly107, Trp193, Asn243 and Arg445. Borate binds in the PLP-binding pocket and forms a hydrogen bond with Asp272. The position of malate in the T84V/ K169V structure approximates the binding of glutamate in the AtPAT K306A structure and a-ketoglutarate in the AtPAT T84V structure. Both structures show that mutations reducing enzymatic activity with prephenate do not alter the global architecture of the active site. The AtPAT T84V and T84V/K169V mutant structures suggest that substitution of side chains that provide hydrogen-bond and/or ionic interactions with apolar residues leads to altered substrate preference, potentially from the loss of key interactions that allow for prephenate binding.
DISCUSSION
When plants moved onto land, the need for lignin, which is the second most abundant organic compound on Earth and makes up roughly 30% of plant biomass, intensified the evolutionary pressures to maintain aromatic amino acid biosynthesis pathways (because phenylalanine is a precursor to lignin biosynthesis) (Boerjan et al., 2003) . Similarly, aromatic amino acids became critical for phenylpropanoids needed for protection against UV light, herbivore and pathogen defense, floral pigmentation and the synthesis of aromatic compounds (Dixon and Paiva, 1995; Corea et al., 2012) . Historically, PAT activity had been detected in plants, but only recently was the gene encoding PAT identified (Graindorge et al., 2010; Maeda et al., 2011) . Here we examined the molecular mechanisms for substrate recognition and inhibition of plant PAT.
Using X-ray crystallography, we captured AtPAT in an open active site conformation with PLP linked to the catalytic lysine as a Schiff base (Figure 2 ). In the active site, multiple residues contact PLP; however, two residues are key for the aminotransferase chemistry. Lys306, which formed an internal aldimine with the bound PLP, clearly serves as the Schiff base during the reaction sequence ( Figure 5 , E+PLP and E-PLP steps). In addition, the interaction between Asp272 and the pyridine nitrogen is a hallmark of aminotransferases, as this interaction maintains a protonated form of the PLP that allows for the ensuing aminotransferase reaction and not other types of chemistry such as decarboxylation, condensation or elimination reactions (Toney, 2014) .
Although PAT and AAT share a common chemistry, these enzymes differ in substrate preference. Amino acid sequence comparison of AtPAT with other AATs highlights conservation of the PLP-binding site ( Figure S2 ), which is consistent with the common reaction chemistry of these enzymes. The crystal structure of the AtPAT K306A mutant in complex with PMP and glutamate provides insight into the substrate-binding site (Figure 2) . In this structure, the amino acid backbone of the ligand is oriented toward Gly107, Glu108 and Arg445, which provides a counterion to the backbone carboxylate group. This positions the amino acid amine toward the PMP in an orientation that would facilitate formation of an external aldimine in the reaction sequence ( Figure 5 , E+PLP-Asp step). In addition, Lys169 forms an ionic interaction with the side-chain carboxylate of the ligand and movement of the a1 helix into the active site places Thr84 opposite the side-chain carbon to provide van der Waals contacts.
The reaction mechanism of aminotransferases involves a ping-pong type reaction sequence and requires the use of a shared binding site for both amino acid and keto acid substrates. Although the AtPAT T84V mutant was crystallized without a cofactor, the position of a-ketoglutarate in the active site (Figure 4b ) reveals a similar set of protein-ligand interactions to the AtPAT K306A•PMP•glutamate complex (Figure 2c, d) . The a-ketoglutarate backbone carboxylate is oriented toward Gly107, Glu108 and Arg445, as observed with bound glutamate. Although Lys169 does not directly interact with a-ketoglutarate, it is possible that with bound prephenate that this residue provides additional contacts with the bridging carboxylate group of the substrate. Moreover, similar interactions with malate were observed in the AtPAT T84V/K169V structure (Figure 4c ).
Biochemical analyses of mutants targeting active site residues identified key residues and molecular mechanisms responsible for reaction chemistry and the substrate preference of PAT (Tables 1 and 2 ). Mutations of Lys306, Arg445 and Lys169 yielded inactive enzymes and the K306A and R445G mutants did not bind amino acid ligands. The X-ray crystal structure of the K306A mutant and the resulting effect on enzymatic activity and ligand binding is consistent with a role for this Lys as the Schiff base in the reaction mechanism, as discussed above. The position of Arg445 in the active site suggests that this residue serves as a counterion to the backbone carboxylate group of the amino acid and keto acid substrates (Figures 2c, d and 4b ). As no signal change was observed in amino acid titrations, elimination of a key ionic interaction provided by Arg445 is likely to alter binding affinity to prevent catalysis. Similarly, the K169S and K169V mutants were inactive; however, the K169S mutant lost aspartate binding with the K169V mutant retaining a binding affinity similar to the wild-type (Table 2) . Overall, these results indicate that Lys169 and Arg445 are key for substrate binding in AtPAT. We propose that these residues facilitate both amino acid and keto acid binding and formation of the external aldimine form of AtPAT, which allows for the donor amine from aspartate to react with the prephenate to form arogenate ( Figure 5 ). Previous studies identified Thr84 and Lys169 of AtPAT as determinants of PAT activity (Dornfeld et al., 2014) ; however, the molecular basis for substrate preference was not addressed. To evaluate the contributions of these residues to substrate preference, we re-examined the effect of mutating Thr84 and Lys169 on PAT activity and ligand binding (Tables 1, 2 and S2) and determined the crystal structures of the AtPAT T84V and T84V/K169V mutants (Figure 4) . Previous work indicated that the T84V mutation reduced PAT activity and that the double mutant abolished both PAT and AAT activity to yield an enzyme that used tryptophan as an amine donor and 4-HPP as a keto acid. Consistent with that study, the T84V mutant displayed reduced catalytic efficiency compared with AtPAT, with the largest effect (10-fold) observed with prephenate (Table 1) . In amino acid titrations, the K d of this mutant for aspartate was comparable to the wild-type value; however, this mutation introduced alanine binding and decreased affinity for tryptophan (Table 2 ). The active sites of the wild-type and T84V AtPAT proteins are structurally similar (Figure 4b) with only the loss of a potential hydrogen-bond donor affecting the K m for prephenate. As mentioned above, the K169 mutations lost PAT activity with aspartate (Table 1) . Examination of amino acid binding showed that the K169V mutant, like the T84V mutant, could bind alanine. The K169S mutant was unable to bind aspartate, which explains why the enzyme was inactive in the coupled assay. Interestingly, the K169S mutant had a higher affinity for tyrosine and tryptophan. These data suggest that the T84V and K169V mutants more readily accommodate smaller ligands such as a-ketoglutarate, alanine and aspartate but filter out larger molecules like prephenate and tryptophan. This is also consistent with conservation of these residues as valine in the Arabidopsis AAT. Differences that lead to the new activity of the double mutant protein are difficult to assess; however, the presence of side chains that provide either hydrogen-bond (Thr84) or charge-charge (Lys169) interactions are key for PAT function.
Structure-guided sequence comparisons ( Figure S2 ) also identified other changes in the active sites, including substitution of Ala168 and Glu108 of AtPAT with glycine and lysine, respectively, of AATs. Kinetic and ligand-binding analyses of the AtPAT A168G mutant indicate that a change at this position has a modest impact on biochemical function (Tables 1 and 2 ). In contrast, the E108K mutant altered the substrate preference of AtPAT (Table 1) . The resulting AtPAT E108K mutant still used prephenate, which suggests that multiple residues contribute to this gain-offunction mutation in an AAT. AtPAT displays a two-fold preference for prephenate versus a-ketoglutarate. Mutation of Glu108 to a lysine shifts the k cat /K m for a-ketoglutarate more than eight-fold compared with prephenate. It should be noted that the AAT versus PAT activity of the E108K mutant is probably greater than this because the enzyme did not display saturation kinetics with prephenate. Moreover, ligand-binding analysis suggests that the E108K mutant is more promiscuous than AtPAT (Table 2 ). The E108K mutant has a higher affinity for aspartate and a lower affinity for glutamate, and can bind tyrosine and tryptophan. In the crystal structures of AtPAT, the side chain of Glu108 is oriented away from the active site with protein-ligand contacts provided by the peptide backbone. It is possible that changes in the side-chain structure may reposition the peptide backbone and influence how ligands fit in the active site. A relaxed ligand-binding preference would be a step toward altering substrate selection. Interestingly, Glu108 is also conserved among class Ib AAT enzymes that do not have PAT activity (Dornfeld et al., 2014) . Thus, the presence of glutamate at position 108 among the class Ib AATs, but not class Ia AATs, might have contributed to the evolution of PAT function.
The ability of AtPAT to bind a range of amino acids led us to examine if these molecules could serve as potential effectors of the enzyme and identified cysteine as an inhibitor of AtPAT (Figures 4a and S4) . Ligand-binding analysis indicates that cysteine forms an external aldimine with PLP (Table S2 ). This suggests that the Cys-PLP aldimine probably prevents the keto acid substrate from reacting with PLP. Two of the active site mutants (K169V and R445G) did not form an external aldimine with cysteine, which suggests that these key substrate interaction residues are also important for binding of this inhibitor molecule (Table S2) . Previous work on PLP-dependent aspartate decarboxylases elucidated a potential cysteine-binding mechanism that leads to irreversible inhibition (Liu et al., 2013) . In these enzymes, cysteine enters the active site and reacts with PLP to form a cysteine-PLP aldimine through nucleophilic addition by the sulfhydryl group and subsequent cyclization. In PAT, we presume that cysteine forms a permanent external aldimine that sterically blocks the active site, but further studies are needed to confirm the irreversible inhibition. To visualize this possible reaction in the AtPAT active site, molecular docking was used to predict the binding of PLP-cysteine in both non-cyclic and cyclic forms (Figures 4b, c) . Either molecule fits in the AtPAT active site and is proximal to substrate-binding and catalytic residues.
PATs from other organisms, including snapdragon and a Gram-negative thermophilic green sulfur Chlorobi bacterium, were also inhibited by cysteine (Figure 4a , Table S2 ). While it was maybe not surprising that another plant PAT is sensitive to Cys, the finding that PAT in a bacterium is inhibited by cysteine was unexpected. This finding also suggests that either the ancestral enzyme that was acquired in plants was sensitive to cysteine or that both plant and microbial enzymes have independently evolved sensitivity to the same amino acid. Cysteine may play a role as an effector molecule across different metabolic pathways in plants, as this amino acid has been identified as an effector for several other plant amino acid biosynthesis enzymes, including aspartate kinase (Curien et al., 2005) , homoserine dehydrogenase (Paris et al., 2003; Rognes et al., 2003) 3-phosphoglycerate dehydrogenase (Okamura and Hirai, 2017) and chorismate mutase (Westfall et al., 2014) . Given that plants need to coordinate a variety of biochemical pathways connected to carbon, nitrogen and sulfur metabolism (Shin et al., 2011) , the use of a biochemical effector to modulate activity across those pathways may contribute to flux between tyrosine/ phenylalanine biosynthesis and tryptophan/chorismatederived metabolite biosynthesis.
EXPERIMENTAL PROCEDURES
Site-directed mutagenesis, protein expression and protein purification
The AtPAT T84V, K169V and T84V/K169V mutant expression constructs, along with AmPAT and CtPAT expression constructs, were previously described (Dornfeld et al., 2014) . The AtPAT E108K, A168G, K169S, K306A and R445G mutants were generated using the codon-optimized AtPAT template (see below) and oligonucleotides containing mutations using the QuikChange PCR method (Stratagene). Codon-optimized AtPAT lacking the chloroplast transit peptide was synthesized (Genewiz, https://www.genewiz.com/) and cloned into the pET28a expression vector. Each construct was transformed into Escherichia coli Rosetta2 (DE3) cells (Novagen, EMD Millipore, http://www.emdmillipore.com/US/en/product/Rose ttaDE3-Competent-Cells-Novagen,EMD_BIO-70954). Cells were cultured in Terrific broth until A 600 nm $ 0.6-0.8, at which time protein expression was induced using a final concentration of 1 mM isopropyl b-D-1-thiogalactopyranoside. After overnight incubation at 16°C, cells were pelleted by centrifugation (5000 g for 10 min) and resuspended in 50 mM 2-amino-2-(hydroxymethyl)-1,3-propanediol (TRIS) (pH 8.0), 500 mM NaCl, 20 mM imidazole, 10% glycerol and 1% Tween-20. Following sonication, cell debris was removed by centrifugation (13 000 g for 45 min) and the resulting lysate was passed over a Ni 2+ -nitrilotriacetic acid (Qiagen, http:// www.qiagen.com/) column equilibrated in the lysis buffer. The column was then washed [50 mM TRIS (pH 8.0), 500 mM NaCl, 20 mM imidazole, 10% glycerol] and bound His-tagged protein eluted [50 mM TRIS (pH 8.0), 500 mM NaCl, 250 mM imidazole, 10% glycerol]. Protein concentration was determined by the Bradford method (Bio-Rad, http://www.bio-rad.com/) with bovine serum albumin as standard.
Protein crystallography
For crystallization, HIs-tagged protein was further purified using a Superdex-75 26/60 HiLoad € AKTA FPLC size-exclusion column (GE Healthcare, http://www.gehealthcare.com/) equilibrated with 25 mM HEPES (pH 7.5) and 100 mM NaCl. Purified wild-type AtPAT and the T84V, T84V/K169V and K306A mutant proteins were concentrated to 12.6, 18.7, 7.0 and 12.5 mg ml
À1
, respectively, and crystallized using the hanging-drop vapor-diffusion method with a 2-ll drop (1:1 concentrated protein and crystallization buffer). Diffraction-quality crystals of the enzyme were obtained at 4°C with a crystallization buffer of 20% PEG-3350, 200 mM magnesium formate and 1 mM PLP for the wild-type structure; 25% PEG-1500, 100 mM MIB buffer (sodium malonate dibasic monohydrate, imidazole, boric acid; pH 5.0), 1 mM PLP and 1 mM Glu for the K306A mutant structure; 20% PEG-6000, 100 mM citric acid (pH 5.0) and 3 mM a-ketoglutarate for the T84V mutant; and 25% PEG-1500 and 100 mM MIB buffer (pH 5.0) for the T84V/K169V mutant structure. Crystals were flash-frozen in liquid nitrogen with mother liquor supplemented with 25% glycerol as a cryoprotectant. Diffraction data (100 K) were collected at the Argonne National Laboratory Advanced Photon Source 19-ID beamline. The data were indexed, scaled and integrated with HKL3000 (Minor et al., 2006) . Molecular replacement was implemented in PHASER (McCoy et al., 2007) using a SwissModel-generated dimer of AAT from Phormidium lapideum (PDB 1J32; 44% amino acid sequence identity) as a search model. The resulting refined AtPAT structure was then used as a search model for each of the AtPAT mutant structures. Iterative rounds of manual model building and refinement used COOT (Emsley and Cowtan, 2004) and PHENIX (Adams et al., 2010) , respectively. Data collection and refinement statistics are summarized in Table S1 .
Kinetic analysis
The PAT activity was determined using a coupled assay system measuring NADH oxidation (Arnold and Parslow, 1995) . Assays were performed using 50 mM HEPES (pH 7.5), 25 mM NaCl, 1 mM NADH, 0.11 mM PLP and three units of malate dehydrogenase in a volume of 100 ll. Aspartate (0-8 mM) was varied with fixed a-ketoglutarate (3 mM) as the keto acid. With fixed aspartate (4 mM), either a-ketoglutarate (0-8 mM) or prephenate (0-2 mM) was varied in assays of the wild-type and the T84V mutant. For the E108K and A168G mutants, 6 mM aspartate was used as the fixed substrate. All reactions were initiated by the addition of protein and conducted at 25°C. Initial velocity data were fitted to the MichaelisMenten equation using GraphPad Prism. Inhibition of AtPAT, AmPAT and CtPAT was analyzed using 3-6 lg of protein with 4 mM aspartate and either 2 mM a-ketoglutarate or 0.5 mM prephenate in the presence of varied amounts of (0-5 mM) cysteine. IC 50 values were determined by fitting data to y = max/ [1 + (I f /IC 50 )], where max is the maximum observed rate difference and I f is the inhibitor concentration, in Prism.
Computational docking of PLP-cysteine forms
Molecular docking of PLP-cysteine into the AtPAT structure was performed using AutoDock Vina (Trott and Olson, 2010) (v.1.1.2) . The active site of the structure was used to guide docking with a grid box of 30 9 30 9 30 A and the exhaustiveness set to 8.
Amino acid-binding analysis
Binding of aspartate, glutamate, alanine, tryptophan, tyrosine and cysteine was measured by observing the change in absorbance upon formation of the external aldimine with PLP using a Beckman Coulter DU800 UV/Vis spectrophotometer. Titrations were performed using 200 lg of protein with 0-12.8 mM amino acid in 0.1 M HEPES (pH 7.5) at 25°C. Apparent 
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